Unique ID issued by UMIN | UMIN000033419 |
---|---|
Receipt number | R000034786 |
Scientific Title | Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study. |
Date of disclosure of the study information | 2018/07/18 |
Last modified on | 2020/01/24 10:07:32 |
Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study.
Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study.
Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study.
Efficacy of resistance training with non-alcoholic fatty liver disease, Randomized control study.
Japan |
fatty liver disease (exclude alcoholic hepatitis)
Hepato-biliary-pancreatic medicine |
Others
NO
Western lifestyle provokes metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). NAFLD requires management of diet and exercise therapy. Decreased body mass improves liver steatosis and fibrosis levels. On the other hand, method of exercise is unclear. Since many NAFLD patients with advanced fibrosis present sarcopenia, the efficacy of resistance training must be evaluated urgently. The purpose of this study is to explore how aerobic exercise and resistance training not only increases muscle strength but also improves AST and ALT.
Efficacy
Not applicable
Improvement of ALT comparing between before and after intervention.
Laboratory data, Body composition analysis (BIA method), amount of physical exertion (activity meter), Specific Activity Scale, Athens Insomnia Scale.
Concurrently, the efficacy of exercise is also studied in non-intervention group (the evaluation items are the same as above).
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
YES
Numbered container method
2
Treatment
Behavior,custom |
Resistance training
4 month
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1. Diagnosed as fatty liver
2. ALT >= 40
3. Aged over 20 years old and under 75
4. PS 0 - 1 (ECOG)
5. Patients who are able to provide written consent to participate in this research in person, follow instructions during participation in this research, and undergo protocol-specified physical examination and other examinations.
Decompensated cirrhosis, Affected malignant tumor in 2-years (exclude carcinoma in situ), heart and lung disease (NYHA > II), percutaneous coronary intervention in 6 month, proliferative diabetic retinopathy, diabetic patient using sulfonylurea / insulin, diabetic neuropathy, severe musculoskeletal impairment, gestation.
50
1st name | |
Middle name | |
Last name | Okajima Akira |
Takeda hospital
Gastroenterology and hepatology
841-5, higashiko-ji cho, simogyo-ku, Kyoto, 600-8558
+81-75-361-1351
aokajima@koto.kpu-m.ac.jp
1st name | |
Middle name | |
Last name | Okajima Akira |
Takeda hospital
Gastroenterology and hepatology
841-5, higashiko-ji cho, simogyo-ku, Kyoto, 600-8558
+81-75-361-1351
aokajima@koto.kpu-m.ac.jp
Takeda hospital
non
Self funding
NO
武田病院 / Takeda hospital
2018 | Year | 07 | Month | 18 | Day |
Unpublished
Terminated
2018 | Year | 05 | Month | 22 | Day |
2018 | Year | 06 | Month | 25 | Day |
2018 | Year | 07 | Month | 23 | Day |
2020 | Year | 03 | Month | 31 | Day |
2018 | Year | 07 | Month | 17 | Day |
2020 | Year | 01 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034786
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |